Use of a modified Atkins diet in intractable childhood epilepsy

Hoon Chul Kang, Hyun Sug Lee, Su Jeong You, Du Cheol Kang, Tae Sung Ko, Heung Dong Kim

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Purpose: To evaluate the efficacy, safety and tolerability of a modified Atkins diet in intractable childhood epilepsy. Methods: Fourteen children with epilepsy were treated prospectively with a modified Atkins diet. Outcome measures included seizure frequency, adverse reactions and tolerability to the diet; blood β-hydroxybutyrate and urine ketones were also measured. Results: Six months after diet initiation, seven (50%) remained on the diet, five (36%) had >50% seizure reduction, and three (21%) were seizure free. The diet was well tolerated by 12 (86%) patients. Most complications were transient and were successfully managed by careful follow-up and conservative strategies. A consistently strong ketosis (β-hydroxybutyrate of >3 mmol/L) seemed to be important for maintaining the efficacy of the diet therapy. Conclusions: The modified Atkins diet was well tolerated and sometimes a modified Atkins diet can be substituted for the conventional ketogenic diet. Serious complications were rare, but long-term complications remain to be determined.

Original languageEnglish
Pages (from-to)182-186
Number of pages5
JournalEpilepsia
Volume48
Issue number1
DOIs
Publication statusPublished - 2007 Jan 1

Fingerprint

Carbohydrate-Restricted Diet
Hydroxybutyrates
Diet
Seizures
Ketogenic Diet
Diet Therapy
Ketosis
Ketones
Epilepsy
Outcome Assessment (Health Care)
Urine
Safety
Drug Resistant Epilepsy

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Cite this

Kang, Hoon Chul ; Lee, Hyun Sug ; You, Su Jeong ; Kang, Du Cheol ; Ko, Tae Sung ; Kim, Heung Dong. / Use of a modified Atkins diet in intractable childhood epilepsy. In: Epilepsia. 2007 ; Vol. 48, No. 1. pp. 182-186.
@article{e4cdfd6fc5344a2e921a1345491b6ee2,
title = "Use of a modified Atkins diet in intractable childhood epilepsy",
abstract = "Purpose: To evaluate the efficacy, safety and tolerability of a modified Atkins diet in intractable childhood epilepsy. Methods: Fourteen children with epilepsy were treated prospectively with a modified Atkins diet. Outcome measures included seizure frequency, adverse reactions and tolerability to the diet; blood β-hydroxybutyrate and urine ketones were also measured. Results: Six months after diet initiation, seven (50{\%}) remained on the diet, five (36{\%}) had >50{\%} seizure reduction, and three (21{\%}) were seizure free. The diet was well tolerated by 12 (86{\%}) patients. Most complications were transient and were successfully managed by careful follow-up and conservative strategies. A consistently strong ketosis (β-hydroxybutyrate of >3 mmol/L) seemed to be important for maintaining the efficacy of the diet therapy. Conclusions: The modified Atkins diet was well tolerated and sometimes a modified Atkins diet can be substituted for the conventional ketogenic diet. Serious complications were rare, but long-term complications remain to be determined.",
author = "Kang, {Hoon Chul} and Lee, {Hyun Sug} and You, {Su Jeong} and Kang, {Du Cheol} and Ko, {Tae Sung} and Kim, {Heung Dong}",
year = "2007",
month = "1",
day = "1",
doi = "10.1111/j.1528-1167.2006.00910.x",
language = "English",
volume = "48",
pages = "182--186",
journal = "Epilepsia",
issn = "0013-9580",
publisher = "Wiley-Blackwell",
number = "1",

}

Use of a modified Atkins diet in intractable childhood epilepsy. / Kang, Hoon Chul; Lee, Hyun Sug; You, Su Jeong; Kang, Du Cheol; Ko, Tae Sung; Kim, Heung Dong.

In: Epilepsia, Vol. 48, No. 1, 01.01.2007, p. 182-186.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Use of a modified Atkins diet in intractable childhood epilepsy

AU - Kang, Hoon Chul

AU - Lee, Hyun Sug

AU - You, Su Jeong

AU - Kang, Du Cheol

AU - Ko, Tae Sung

AU - Kim, Heung Dong

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Purpose: To evaluate the efficacy, safety and tolerability of a modified Atkins diet in intractable childhood epilepsy. Methods: Fourteen children with epilepsy were treated prospectively with a modified Atkins diet. Outcome measures included seizure frequency, adverse reactions and tolerability to the diet; blood β-hydroxybutyrate and urine ketones were also measured. Results: Six months after diet initiation, seven (50%) remained on the diet, five (36%) had >50% seizure reduction, and three (21%) were seizure free. The diet was well tolerated by 12 (86%) patients. Most complications were transient and were successfully managed by careful follow-up and conservative strategies. A consistently strong ketosis (β-hydroxybutyrate of >3 mmol/L) seemed to be important for maintaining the efficacy of the diet therapy. Conclusions: The modified Atkins diet was well tolerated and sometimes a modified Atkins diet can be substituted for the conventional ketogenic diet. Serious complications were rare, but long-term complications remain to be determined.

AB - Purpose: To evaluate the efficacy, safety and tolerability of a modified Atkins diet in intractable childhood epilepsy. Methods: Fourteen children with epilepsy were treated prospectively with a modified Atkins diet. Outcome measures included seizure frequency, adverse reactions and tolerability to the diet; blood β-hydroxybutyrate and urine ketones were also measured. Results: Six months after diet initiation, seven (50%) remained on the diet, five (36%) had >50% seizure reduction, and three (21%) were seizure free. The diet was well tolerated by 12 (86%) patients. Most complications were transient and were successfully managed by careful follow-up and conservative strategies. A consistently strong ketosis (β-hydroxybutyrate of >3 mmol/L) seemed to be important for maintaining the efficacy of the diet therapy. Conclusions: The modified Atkins diet was well tolerated and sometimes a modified Atkins diet can be substituted for the conventional ketogenic diet. Serious complications were rare, but long-term complications remain to be determined.

UR - http://www.scopus.com/inward/record.url?scp=33846216385&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846216385&partnerID=8YFLogxK

U2 - 10.1111/j.1528-1167.2006.00910.x

DO - 10.1111/j.1528-1167.2006.00910.x

M3 - Article

C2 - 17241226

AN - SCOPUS:33846216385

VL - 48

SP - 182

EP - 186

JO - Epilepsia

JF - Epilepsia

SN - 0013-9580

IS - 1

ER -